throbber
IN THE UNITED STATES DISTRICT COURT
`
`IN AND FOR THE DISTRICT OF DELAWARE
`
`ASTRAZENECA AB,
`
`Civil Action
`
`No. 14—664~GMS
`
`Civil Action
`
`No.
`
`14—666—GMS
`
`Civil Action
`
`_
`
`No.
`
`14—667—GMS
`
`~4sa~e\/sayasagagae
`
`) ) ) ) ) ) )
`
`)
`
`) )
`
`\z\/\.4\/\.a\/sax/sax;
`
`Plaintiff,
`
`V.
`
`AUROBINDO PHARMA LTD. AND
`
`AUROBINDO PHARMA U.S.A.,
`
`INC.,
`
`Defendants.
`
`ASTRAZENECA AB,
`
`Plaintiff,
`
`V.
`
`INC. ,
`WATSON LABORATORIES,
`ACTAVIS,
`INC. , and ACTAVIS LLC,
`
`Defendants.
`
`ASTRAZENECA AB,
`
`Plaintiff,
`
`V.
`
`WOCKHARDT BIO AG and
`
`WOCKHARDT USA LLC,
`
`Defendants.
`
`._
`
`_
`
`Wilmington, Delaware
`Wednesday, September 21, 2016
`9:00 a.m.
`
`Day 3 of Bench Trial
`
`BEFORE:
`
`HONORABLE GREGORY M. SLEET, U.S.D.C.J.
`
`CAPTION CONTINUES ON FOLLOWING PAGE
`
`Page 1 of 6
`
`AstraZeneca Exhibit 2218
`Mylan v. AstraZeneca
`IPR2015-01340
`
`

`
`406
`
`IN THE UNITED STATES DISTRICT COURT
`
`IN AND FOR THE DISTRICT OF DELAWARE
`
`ASTRAZENECA AB,
`
`Civil Action
`
`Plaintiff,
`
`V.
`
`SUN PHARMA GLOBAL FZE and SUN
`
`PHARMACEUTICAL INDUSTRIES LTD.,
`
`Defendants.
`
`ASTRAZENECA AB,
`
`Plaintiff,
`
`V.
`
`MYLAN PHARMACEUTICALS,
`
`INC.
`
`I
`
`Defendant.
`
`ASTRAZENECA AB,
`
`Plaintiff,
`
`V.
`
`AMNEAL PHARMACEUTICALS LLC,
`
`Defendant.
`
`
`
`sJ\.a~a;\/xaxas/xaxzx/\./\./\/xysaexesr
`
`s/~.z\/\a\¢\.r\.¢\a\/
`
`No. 14-694-GMS
`
`Civil Action
`
`No. 14-696-GMS
`
`Civil Action
`
`No. 14-697-GMS
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Page 2 of 6
`
`Page 2 of 6
`
`

`
`APPEARANCES:
`
`407
`
`MICHAEL P. KELLY, ESQ., and
`DANIEL M. SILVER, ESQ.
`
`McCarter & English, LLP
`—and—
`
`CHARLES E. LIPSEY, ESQ.,
`ROBERT F. SHAFFER, ESQ.,
`
`DAVID M. WEINGARTEN, Ph.D., ESQ., and
`NICOLE A CONLON, Ph.D., ESQ.
`
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, L.L.P.
`
`(Washington, D.C.)
`
`Counsel for Astrazeneca AB
`
`KENNETH LAURENCE DORSNEY, ESQ.
`Morris James LLP
`—and—
`
`SAILESH K. PATEL, ESQ., and
`GEORGE YU, ESQ.
`Schiff Hardin LLP
`
`(New York, NY)
`
`Counsel for Aurobindo
`
`DOMINICK T. GATTUSO, ESQ.
`Proctor Heyman LLP
`—and-
`
`RALPH J. GABRIC, ESQ.,
`MARK H. REMUS, ESQ.,
`LAURA A. LYDIGSEN, ESQ., and
`JOSHUA JAMS, ESQ.
`Brinks Gilson & Lione
`
`(Chicago,
`
`IL)
`
`Counsel for Watson
`Laboratories and Actavis
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Page 3 of 6
`
`Page 3 of 6
`
`

`
`APPEARANCES CONTINUED:
`
`408
`
`DAVID BILSON, ESQ.
`
`Phillips, Goldman, McLaughlin & Hall, P.A.
`- and:
`MAUREEN L. RURKA, ESQ., and
`CHRISTOPHER P. WILSON, ESQ.
`Winston & Strawn LLP
`
`(Chicago,
`
`IL)
`
`Counsel for Sun Pharma Global
`FZE and Sun Pharmaceutical
`and Amneal
`
`DAVID E. MOORE, ESQ.
`Potter Anderson & Corroon LLP
`—and—
`
`DOUGLAS H. CARSTEN, ESQ.,
`ELLIE F. STEINER, ESQ., and
`NELLIE AMJADA, ESQ.
`Wilson Sonsini Goodrich & Rosati
`
`(San Diego, CA)
`
`Counsel for Mylan
`
`1
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`L7
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Page 4 of 6
`
`Page 4 of 6
`
`

`
`560
`
`M.
`
`JAM$5
`
`Thank you, your honor.
`
`Joshua James
`
`representing Actavis on behalf of all defendants.
`
`I introduce the deposition testimony and all
`
`relevant exhibits for Cheryl Fassak,
`
`lead for AstraZeneca's
`
`portfolio marketing team in the diabetes franchise.
`
`Both defendants and plaintiffs have identified
`
`testimony, eight minutes on behalf of the defendants,
`
`two
`
`minutes on behalf of plaintiffs.
`
`THE COURT: Great.
`
`(The videotaped deposition of Cheryl Fassak was
`
`played as follows.)
`
`"Question: Please state your name for the
`
`record.
`
`"Answer: Cheryl Fassak.
`
`
`
`
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Page 5 of 6
`
`Page 5 of 6
`
`

`
`Fassak — depo.
`
`567
`
`"Question: Did Caremark inform Astrazeneca
`
`or BMS why it went to a not covered tier on its formulary?
`
`"Answer:
`
`So, specifically —— so they informed
`
`us of the decision.
`
`They informed us that they —— they were
`
`evaluating rebates and that they had gone with another
`
`option with a higher rebate.
`
`"Question:
`
`Do you know if that other option was
`
`Januvia?
`
`"Answer:
`
`I'm not sure.
`
`"Question:
`
`Is that what your suspicion is?
`
`"Answer: Yes.
`
`(End of videotaped deposition.)
`
`
`
`10
`
`11
`
`12
`
`13
`
`14
`
`15
`
`16
`
`17
`
`18
`
`19
`
`20
`
`21
`
`22
`
`23
`
`24
`
`25
`
`Page 6 of 6
`
`Page 6 of 6

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket